We are actively working to ensure that the voice of oncology in South Carolina is heard. Explore our website for the latest updates in oncology and healthcare-related legislation in South Carolina, discover SCOS' advocacy on the state and federal level, and more.
SCOS values your input. Help us make a difference in our state. Do you know a South Carolina State Legislature member? Do you have an issue you want brought to the attention of the state legislature? Please contact us with all questions and comments.
April 9, 2021
This week was crossover week in the General Assembly, as the Senate and House of Representatives debated dozens of bills on the calendars in an attempt to achieve second and third reading before April 10th. Senate Finance budget subcommittees heard agency requests from the Department of Education, the newly formed Office of Resilience, the Department of Transportation and others in addition to proviso review to prepare for full Senate Finance Committee debate of the budget next week. Senate floor debate of the budget is scheduled for the week of April 26.
SCOS Joins Coalition Letter Urging Addition of the Cures 2.0 Concept Paper Title IV Provisions in the Next COVID-19 Relief Package
The South Carolina Oncology Society (SCOS) joined in a coalition letter to congressional leadership urging that Congress include the 21st Century Cures 2.0 concept paper, recently released by Representatives Diana DeGette and Fred Upton in upcoming legislation to further address the COVID-19 public health crisis. Specifically the letter urges leadership to include policy to provide Medicaid coverage of the routine care costs of clinical trials participation for patients with life-threatening conditions in every state. This critical protection is championed by Representatives Ben Ray Luján and Gus Bilirakis in the Clinical Treatment Act (H.R. 913).
ACCC members were invited to join legal experts and their ACCC colleagues for a one-hour overview and discussion about the Centers for Medicare & Medicaid Services (CMS) final CY 2020 OPPS and PFS rules. The webinar covered key proposals the agency has finalized under the OPPS that will affect next year’s payments for 340B hospitals, excepted off-campus provider-based departments (PBDs), as well as updates to the administration's pricing transparency and drug pricing reform efforts. A recording of this webinar, presentation slides, and rule summaries are available to ACCC members.
ACCC members can access summaries of the final rules here. [Requires Login] Also available, a summary of selected provisions of the CY2020 Hospital Price Transparency Requirements for Hospitals to Make Standard Charges Public final rule. [Requires Login]
View On-Demand Webinar Replay (Requires Login)